Has Nancy Devries received payments from drug or device companies?

Yes. Drug and device makers reported $13,356 in general payments to Nancy Devries across 626 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nancy Devries did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nancy Devries come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nancy Devries

Family · Sarasota, FLNPI 1902358310

Payments from drug & device makers

$13,356in general payments, 2019–2025

Across 626 payments — averaging $21.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$1K
Novartis$939
Merck$909
Incyte Corporation$793
Gilead$758
Johnson & Johnson$712
plus $8K from 54 others

What the payments were for

Food & beverage$12,60294%
Education$7536%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	49	$1,065
Novartis	60	$939
Merck	35	$909
Incyte Corporation	29	$793
Gilead(2 entities)	35	$758
Johnson & Johnson	45	$712
Daiichi Sankyo Inc.	25	$664
Bristol Myers Squibb	27	$656
Pfizer	32	$576
Takeda Pharmaceuticals U.S.A., Inc.	27	$547
Seagen Inc.	19	$457
E.r. Squibb & Sons, L.L.C.	20	$451
AbbVie	15	$323
Beigene USA, Inc.	16	$294
GSK	16	$289
Lilly USA, LLC	10	$235
Eisai Inc.	12	$233
Array Biopharma Inc	10	$203
Ipsen Biopharmaceuticals, Inc	3	$196
Regeneron Healthcare Solutions, Inc.	6	$189
Karyopharm Therapeutics Inc.	5	$186
Jazz Pharmaceuticals Inc.	8	$182
EMD Serono, Inc.	8	$137
Intuitive Surgical	1	$135
Astellas Pharma US Inc	7	$129
Taiho Oncology, Inc.	7	$117
Pulmonx Corporation	1	$110
Pharmaessentia USA Corporation	4	$109
Tersera Therapeutics LLC	4	$109
Boehringer Ingelheim	5	$109
Pharmacyclics LLC, An Abbvie Company	4	$104
Beone Medicines USA, Inc.	4	$94
Sanofi	5	$92
Genentech USA, Inc.	6	$92
Geron Corporation	4	$88
Stemline Therapeutics Inc.	4	$77
Amgen	5	$76
Sumitomo Pharma America, Inc.	5	$72
Sobi, Inc	4	$71
Pharmacosmos Therapeutics Inc.	4	$69
Myriad Genetic Laboratories, Inc.	3	$59
Recordati_rare_diseases_inc.	3	$58
AVEO Pharmaceuticals, Inc.	3	$51
Puma Biotechnology, Inc.	3	$49
Bayer	3	$42
Genmab U.S., Inc.	2	$38
Legend Biotech USA Inc.	1	$37
Blueprint Medicines Corporation	1	$36
Deciphera Pharmaceuticals Inc.	2	$31
Immunocore Limited	1	$30
G1 Therapeutics, Inc.	2	$30
Dendreon Pharmaceuticals LLC	1	$24
Kyowa Kirin, Inc.	1	$23
Viiv Healthcare Company	1	$23
Foundation Medicine, Inc.	1	$16
Novocure Inc.	1	$16
Fennec Pharmaceuticals, Inc.	1	$16
Myovant Sciences Inc.	1	$15
Iovance Biotherapeutics, Inc.	1	$15
Mirati Therapeutics, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,356 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Zolpidem Tartrate	30	$352
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine	16	$328
Tramadol Hcl	23	$300
Lorazepam	36	$260
Alprazolam	42	$254

Paid to pharmacies, not to this prescriber.

Other family in Sarasota

Marie ZambelliSarasota$65K
John HuffakerVenice$8M
Stephanie MompointMiami$4.5M
Miguel TrujilloMiami Gardens$4.4M
Itsel Cardenas RamonMiami$1M
Lewis HarringtonTampa$954K
Adam StrosbergFort Lauderdale$859K
Danielle PharesFt Lauderdale$713K
David RodriguezHialeah$658K
Donna OrtizOrlando$417K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →